scholarly article | Q13442814 |
P50 | author | Karin E. Bornfeldt | Q87887672 |
P2860 | cites work | Obesity, Metabolic Syndrome, and Cardiovascular Disease | Q22241664 |
Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes | Q22250887 | ||
Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice | Q24530027 | ||
Atherosclerosis — An Inflammatory Disease | Q26776972 | ||
Vascular cellular adhesion molecule-1 (VCAM-1) expression in mice retinal vessels is affected by both hyperglycemia and hyperlipidemia | Q27320203 | ||
Inflammation determines the pro-adhesive properties of high extracellular d-glucose in human endothelial cells in vitro and rat microvessels in vivo | Q27331780 | ||
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group | Q27860882 | ||
Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells | Q28509783 | ||
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes | Q29547541 | ||
Effects of intensive glucose lowering in type 2 diabetes | Q29547736 | ||
Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E | Q29615236 | ||
Oxidative Stress and Diabetic Complications | Q29615423 | ||
Glucose control and vascular complications in veterans with type 2 diabetes | Q29619213 | ||
Myeloid lineage cell-restricted insulin resistance protects apolipoproteinE-deficient mice against atherosclerosis | Q30412997 | ||
Accelerated atherosclerosis in Apoe-/- mice heterozygous for the insulin receptor and the insulin receptor substrate-1 | Q30418857 | ||
Elevated glucose and diabetes promote interleukin-12 cytokine gene expression in mouse macrophages | Q30439419 | ||
The pathogenesis of atherosclerosis (first of two parts) | Q33492794 | ||
Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands | Q33556567 | ||
Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis | Q33734679 | ||
Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice | Q34142722 | ||
Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis | Q34207431 | ||
Increase in GLUT1 in Smooth Muscle Alters Vascular Contractility and Increases Inflammation in Response to Vascular Injury | Q34459819 | ||
Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice | Q34485920 | ||
Diabetes adversely affects macrophages during atherosclerotic plaque regression in mice | Q35043471 | ||
Monocyte trafficking in acute and chronic inflammation | Q35230750 | ||
Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions | Q35687871 | ||
Human aldose reductase expression accelerates atherosclerosis in diabetic apolipoprotein E-/- mice | Q35753067 | ||
Abnormal NF-kappa B function characterizes human type 1 diabetes dendritic cells and monocytes | Q46739819 | ||
Insufficient glycemic control increases nuclear factor-kappa B binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetes | Q47693425 | ||
Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes. | Q51501073 | ||
Molecular mechanisms of atherosclerosis in metabolic syndrome: role of reduced IRS2-dependent signaling. | Q52589303 | ||
Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. II. Cellular composition and proliferation. | Q54161571 | ||
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. | Q54225577 | ||
Inflammatory stress in primary venous and aortic endothelial cells of type 1 diabetic mice. | Q54433790 | ||
Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions. | Q54610885 | ||
NADPH Oxidase 1 Plays a Key Role in Diabetes Mellitus–Accelerated Atherosclerosis | Q56991358 | ||
Lack of the Antioxidant Enzyme Glutathione Peroxidase-1 Accelerates Atherosclerosis in Diabetic Apolipoprotein E–Deficient Mice | Q59284858 | ||
Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes | Q62583515 | ||
Two classes of PDGF receptor recognize different isoforms of PDGF | Q69828348 | ||
Absence of correlation between coronary arterial atherosclerosis and severity or duration of diabetes mellitus of adult onset | Q71322456 | ||
Relation of glycohemoglobin and adiposity to atherosclerosis in youth. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group | Q72235731 | ||
Accelerated atherosclerosis and premature calcified cartilaginous metaplasia in the aorta of diabetic male Apo E knockout mice can be prevented by chronic treatment with 17 beta-estradiol | Q78004667 | ||
Type 2 Diabetes and Lipoprotein Metabolism Affect LPS-Induced Cytokine and Chemokine Release in Primary Human Monocytes | Q82589645 | ||
The Role of Toll-Like Receptors in Diabetes-Induced Inflammation: Implications for Vascular Complications | Q83401137 | ||
Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1. | Q35849515 | ||
Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene? | Q36015697 | ||
Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state | Q36459935 | ||
Aldose reductase protects against early atherosclerotic lesion formation in apolipoprotein E-null mice | Q36543639 | ||
Diabetic atherosclerosis in APOE*4 mice: synergy between lipoprotein metabolism and vascular inflammation | Q36658372 | ||
Acyl-CoA synthetase 1 is induced by Gram-negative bacteria and lipopolysaccharide and is required for phospholipid turnover in stimulated macrophages | Q36742281 | ||
Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery disease | Q36753752 | ||
Do glucose and lipids exert independent effects on atherosclerotic lesion initiation or progression to advanced plaques? | Q36775094 | ||
Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice | Q36867835 | ||
Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice. | Q36883079 | ||
Distinct monocyte gene-expression profiles in autoimmune diabetes | Q36906389 | ||
Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia | Q36916418 | ||
Closing the loop on inflammation and atherothrombosis: why perform the CIRT and CANTOS trials? | Q37026106 | ||
Monocyte-endothelial cell interactions in the development of atherosclerosis | Q37116502 | ||
Local proliferation dominates lesional macrophage accumulation in atherosclerosis | Q37161176 | ||
Increased atherosclerosis in streptozotocin-induced diabetic mice | Q37353969 | ||
Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells | Q37405753 | ||
A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro | Q37438001 | ||
Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions | Q37486465 | ||
Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis | Q37711215 | ||
Aldose reductase and cardiovascular diseases, creating human-like diabetic complications in an experimental model. | Q37751655 | ||
Intraplaque haemorrhages as the trigger of plaque vulnerability | Q37852494 | ||
Unlocking the biology of RAGE in diabetic microvascular complications | Q38134924 | ||
TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice. | Q39260793 | ||
The pathogenesis of atherosclerosis (second of two parts) | Q40547842 | ||
Molecular mechanisms of tumor necrosis factor alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways | Q40876050 | ||
The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers | Q41141776 | ||
Diabetes and cardiovascular disease. The Framingham study | Q41509493 | ||
Diabetes mellitus accelerates cartilaginous metaplasia and calcification in atherosclerotic vessels of LDLr mutant mice | Q42405231 | ||
Platelet-derived growth factor. II. Specific binding to cultured cells | Q42825333 | ||
Short-term hyperglycaemia causes non-reversible changes in arterial gene expression in a fully ‘switchable’ in vivo mouse model of diabetes | Q42906142 | ||
Effects of nonlipid risk factors on atherosclerosis in youth with a favorable lipoprotein profile | Q43546643 | ||
Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes | Q43565027 | ||
Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: lack of direct growth-promoting effects of high glucose levels | Q43566166 | ||
Elevated ambient glucose induces acute inflammatory events in the microvasculature: effects of insulin | Q43606088 | ||
Carotid artery intima-media thickness in children with type 1 diabetes | Q43867572 | ||
Endothelium-dependent and -independent vascular dysfunction in type 1 diabetes: role of conventional risk factors, sex, and glycemic control | Q44417109 | ||
Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study | Q44895725 | ||
Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesions, and extent of atherosclerosis in LDL receptor-deficient mice | Q45120387 | ||
Hyperlipidemia in concert with hyperglycemia stimulates the proliferation of macrophages in atherosclerotic lesions: potential role of glucose-oxidized LDL. | Q45161321 | ||
Activation of peripheral blood CD14+ monocytes occurs in diabetes | Q46670144 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | atherosclerosis | Q12252367 |
P304 | page(s) | 705-714 | |
P577 | publication date | 2014-04-01 | |
P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
P1476 | title | 2013 Russell Ross memorial lecture in vascular biology: cellular and molecular mechanisms of diabetes mellitus-accelerated atherosclerosis | |
P478 | volume | 34 |
Q57134943 | Activated protein C reverses epigenetically sustained p66 expression in plaque-associated macrophages in diabetes |
Q39071314 | Arterial Calcification in Diabetes Mellitus: Preclinical Models and Translational Implications. |
Q35868161 | Balloon Angioplasty - The Legacy of Andreas Grüntzig, M.D. (1939-1985) |
Q37011769 | Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations |
Q34393408 | Dicarbonyl stress and atherosclerosis: is it all RAGE? |
Q58571918 | Endothelial-Vascular Smooth Muscle Cells Interactions in Atherosclerosis |
Q90650768 | Hyperglycaemia, ejection fraction and the risk of heart failure or cardiovascular death in patients with type 2 diabetes and a recent acute coronary syndrome |
Q50541242 | Inflammation and myointimal hyperplasia. Correlation with hemodynamic forces. |
Q36021915 | Morphometric and histological parameters in veins of diabetic patients undergoing brachiocephalic fistula placement |
Q28081466 | Noncoding RNA in age-related cardiovascular diseases |
Q46305214 | Resveratrol attenuates high glucose-induced endothelial cell apoptosis via mediation of store-operated calcium entry |
Q60921126 | Thoracic aortic calcification across the clinical dysglycemic continuum in a large Asian population free of cardiovascular symptoms |
Q35881759 | Uncomplicating the Macrovascular Complications of Diabetes: The 2014 Edwin Bierman Award Lecture |
Search more.